Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 13, 2015 1:33 PM ET


Company Overview of Progen Pharmaceuticals, Inc.

Company Overview

Progen Pharmaceuticals, Inc. develops pharmaceutical products for the treatment of anti-proliferation and cancer therapeutics. The company’s products are also used for the treatment of various diseases, including age-related macular degeneration, infectious diseases, inflammatory diseases, and vascular hyperplasia. Progen Pharmaceuticals, Inc. was formerly known as CellGate, Inc. and changed its name to Progen Pharmaceuticals, Inc. in February, 2008 as a result of its acquisition by Progen Pharmaceuticals Limited. The company was founded in 1998 and is based in Palo Alto, California. As of February 7, 2008, Progen Pharmaceuticals, Inc. operates as a subsidiary of Progen Pharmaceuticals Limi...

2479 East Bayshore Road

Suite 709

Palo Alto, CA 94303

United States

Founded in 1998





Key Executives for Progen Pharmaceuticals, Inc.

Co-Founder and Director
Age: 72
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Boca Pharmacal, Inc. United States
Rivanna Pharmaceuticals Inc. United States
Aveva Drug Delivery Systems, Inc. United States
Hanford Pharmaceuticals, LLC United States
Stiefel Laboratories, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Progen Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at